Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance
PROVIDERS
Providers Aldesleukin

Aldesleukin

Trade Name

Proleukin

Class

Immunomodulator: IL-2

Cancer Indication

Renal cell carcinoma, melanoma

Cardiotoxic Side Effects

Hypotension Arrhythmia Restricted to patients with normal cardiac and pulmonary function (FDA Label Warning)

Cardiac Arrythmia (SVT, Ventricular) (NOT most common one) Angina (FDA Label Warning) Myocardial Infarction (FDA Label Warning) Hypotension (71%; grade 4: 3%), peripheral edema (28%), tachycardia (23%), edema (15%), vasodilation (13%), supraventricular tachycardia (12%),Arrhythmia (10%), cardiac arrest (grade 4: 1%), MI (grade 4: 1%), ventricular tachycardia (grade 4: 1%)

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf